Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pyle

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Progress in Clinical and Biological Research|January 1, 1996
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer modelL A Donehower, L A Godley, C M Aldaz, et al.
Cancer Biology & Therapy|December 14, 2011
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenaseMee Young Chang, Courtney Smith, James B DuHadaway, et al.
The Journal of the Arkansas Medical Society|December 1, 1972
End-stage renal disease: management in Arkansas 1972. The changing sceneW J Flanigan, G L Ackerman, G L Barbour, et al.
ACS Nano|February 22, 2017
Molecular Engineering and Design of Semiconducting Polymer Dots with Narrow-Band, Near-Infrared Emission for in Vivo Biological ImagingChi-Shiang Ke, Chia-Chia Fang, Jia-Ying Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsRoshani R Patel, Surojeet Sengupta, Helen R Kim, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2006
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrantEric A Ariazi, Joan S Lewis-Wambi, Shaun D Gill, et al.
Chemical Science|February 5, 2019
Molecular design of near-infrared fluorescent Pdots for tumor targeting: aggregation-induced emission <i>versus</i> anti-aggregation-caused quenchingWei-Kai Tsai, Chun-I Wang, Chia-Hsien Liao, et al.
Molecular Cancer Therapeutics|November 9, 2007
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgenEric A Ariazi, Andrei Leitão, Tudor I Oprea, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Progress in Clinical and Biological Research|January 1, 1996
The role of p53 loss in genomic instability and tumor progression in a murine mammary cancer modelL A Donehower, L A Godley, C M Aldaz, et al.
Cancer Biology & Therapy|December 14, 2011
Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenaseMee Young Chang, Courtney Smith, James B DuHadaway, et al.
The Journal of the Arkansas Medical Society|December 1, 1972
End-stage renal disease: management in Arkansas 1972. The changing sceneW J Flanigan, G L Ackerman, G L Barbour, et al.
ACS Nano|February 22, 2017
Molecular Engineering and Design of Semiconducting Polymer Dots with Narrow-Band, Near-Infrared Emission for in Vivo Biological ImagingChi-Shiang Ke, Chia-Chia Fang, Jia-Ying Yan, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Experimental treatment of oestrogen receptor (ER) positive breast cancer with tamoxifen and brivanib alaninate, a VEGFR-2/FGFR-1 kinase inhibitor: a potential clinical application of angiogenesis inhibitorsRoshani R Patel, Surojeet Sengupta, Helen R Kim, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2006
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrantEric A Ariazi, Joan S Lewis-Wambi, Shaun D Gill, et al.
Chemical Science|February 5, 2019
Molecular design of near-infrared fluorescent Pdots for tumor targeting: aggregation-induced emission <i>versus</i> anti-aggregation-caused quenchingWei-Kai Tsai, Chun-I Wang, Chia-Hsien Liao, et al.
Molecular Cancer Therapeutics|November 9, 2007
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgenEric A Ariazi, Andrei Leitão, Tudor I Oprea, et al.
Pageof 6